about
Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of ageSafety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein--conjugated pneumococcal vaccine in Filipino infantsMucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse.Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies.Validation of a multiplex pneumococcal serotyping assay with clinical samples.Synthesis, conjugation, and immunological evaluation of the serogroup 6 pneumococcal oligosaccharidesContribution of a response regulator to the virulence of Streptococcus pneumoniae is strain dependentSafety and efficacy of meningococcal group C conjugate vaccines.FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis.N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines.IgM in microbial infections: taken for granted?Carbohydrate-based vaccines: challenges and opportunities.Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens.Pneumococcemia in children--a retrospective study before universal pneumococcal vaccinations.Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(f).Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin.CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression.Immunopathogenesis of infectious disease: injury and death from friendly fire.
P2860
Q24245934-6C801D1C-BEFB-4F57-B7E1-2F90EDA4A683Q24795590-D9A747DA-2F50-4539-9528-BD5D99A5FAAEQ28187952-8F362627-EF0C-475B-90C7-7D202260651FQ33208122-1164A3F5-6FB5-44A5-B5AE-8DF19BD5A5ECQ33592895-D711149F-9C22-49AD-AC8F-BF07053E544BQ34345170-ACC3C7C2-283E-423E-8967-F66BB5AF1A14Q35155427-EC8B2BFC-FBE7-418A-8479-54B907E486FCQ35165573-5F0A897C-A1C6-4EC1-869F-7FC2D6554A07Q35194432-F94D59FE-292D-4DE0-9230-49090EDCB7B4Q36403918-CA62FB1D-8D3D-4A68-9C8F-DA0B9785ABA5Q36445780-3288AF69-B15A-43E7-AA48-7214FAE1429FQ37524875-E63BEC89-BB17-48B6-AE2D-3C9445DF23DBQ37810597-55A2D0AB-7EF7-4D88-A945-10F246BCCA37Q39034572-2A40B0DB-3E92-48DB-94F9-93516A234775Q40257918-C4496D46-EA1F-4ECC-B632-3DEE2130BF62Q40265963-093E8E3A-3EB1-4778-882D-E34A95E08A25Q41195561-8ED7B14D-BA7B-4A99-929D-051DF2FC12DBQ43082920-BB0B5F46-B85B-43E7-BD80-86CC5FF9CF42Q47845007-3BE046B1-FA53-46B4-AE7D-60068801FC6F
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Current state of pneumococcal vaccines.
@ast
Current state of pneumococcal vaccines.
@en
Current state of pneumococcal vaccines.
@nl
type
label
Current state of pneumococcal vaccines.
@ast
Current state of pneumococcal vaccines.
@en
Current state of pneumococcal vaccines.
@nl
prefLabel
Current state of pneumococcal vaccines.
@ast
Current state of pneumococcal vaccines.
@en
Current state of pneumococcal vaccines.
@nl
P2860
P1476
Current state of pneumococcal vaccines.
@en
P2093
P2860
P304
P356
10.1046/J.1365-3083.2002.01124.X
P577
2002-08-01T00:00:00Z